中国飞鹤(06186)发布公告，于2025年12月12日斥资2317.9万港元回购565.5万股。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 中國飛鶴有限公司 呈交日期： 2025年12月12日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 06186 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事 ...

证券时报·数据宝统计，中国飞鹤在港交所公告显示，12月11日以每股4.08港元的价格回购196.90万股， 回购金额达803.35万港元。该股当日收盘价4.090港元，下跌1.68%，全天成交额7379.44万港元。 （文章来源：证券时报网） 自10月24日以来公司已连续34日进行回购，合计回购2.29亿股，累计回购金额9.71亿港元。 其间该股累 计上涨1.74%。 今年以来该股累计进行36次回购，合计回购2.31亿股，累计回购金额9.81亿港元。（数据宝） 中国飞鹤回购明细 | 日期 | 回购股数（万股） | 回购最高价（港元） | 回购最低价（港元） | 回购金额（万港元） | | --- | --- | --- | --- | --- | | 2025.12.11 | 196.90 | 4.080 | | 803.35 | | 2025.12.10 | 547.00 | 4.200 | 4.120 | 2293.91 | | 2025.12.09 | 800.70 | 4.120 | 4.070 | 3292.83 | | 2025.12.08 | 700.00 | 4.130 | 4.090 | 2 ...

Core Viewpoint - Feihe and JD.com have launched two groundbreaking products, Jicui and Qicui, marking a significant innovation in the infant nutrition sector, aimed at meeting the nutritional needs of Chinese babies and leading the industry into a new era of "breast milk-like formula + fresh active technology" [1][3]. Group 1: Product Innovation - The new products focus on "fresh active nutrition," addressing core consumer demands, with 78% of educated mothers prioritizing "active nutrition" and "good absorption" when selecting infant formula [3]. - Feihe's innovation includes the first-ever integration of "fresh raw materials" into the freshness standard of infant formula, creating a closed-loop system from fresh sources to self-produced active ingredients [3][5]. Group 2: Production and Quality - Feihe has achieved self-production capabilities for 11 key raw materials, enhancing freshness by at least 23 times and demonstrating a 6.4 times improvement in absorption [5]. - The products utilize fresh raw materials produced within 30 days, significantly reducing the freshness timeline from years to days, with proprietary extraction techniques ensuring superior quality [5][10]. Group 3: Research and Development - Feihe has established one of China's largest breast milk databases and leads national initiatives in breast milk research, accumulating significant findings that inform product development [8]. - The company holds three leading positions in the industry: first in breast milk research achievements, first in infant formula patents, and first in maternal source nutrition branding [8][10]. Group 4: Clinical Validation - Feihe adheres to a "clinical first, market second" approach, conducting rigorous clinical trials before product launch, ensuring high standards of evidence for the efficacy of Jicui and Qicui [13]. - The clinical trials utilized RCT (randomized controlled trial) designs, achieving compliance with the highest global standards, thus validating the products' nutritional claims [13][16]. Group 5: Nutritional Benefits - Jicui's formula emphasizes a dual-source protective system, enhancing the baby's gut health and immune system, with evidence showing a 10.6% increase in the baby's immunoglobulin sIgA levels [10][17]. - Qicui focuses on brain development, incorporating a unique nutritional structure that mimics breast milk, leading to significant improvements in sleep patterns and cognitive development metrics [12][17]. Group 6: Market Positioning - The launch of Jicui and Qicui represents not just a formula upgrade but a strategic innovation tailored for Chinese infants, setting a new value benchmark in the infant formula industry [17]. - Feihe aims to continue providing products that support scientific nutrition, contributing to the future potential of children and the nation [17].

格隆汇12月11日丨中国飞鹤(06186.HK)发布公告，2025年12月11日耗资803.4万港元回购196.9万股，回 购价格每股4.08港元。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 中國飛鶴有限公司 呈交日期： 2025年12月11日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 06186 | 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | | 已發行股份（不包括庫 ...

Summary of Key Points Core Viewpoint - A total of 30 companies conducted share buybacks on December 10, 2025, with Tencent Holdings (00700) leading in both the number of shares repurchased and the total amount spent on buybacks. Group 1: Companies with Significant Buybacks - Tencent Holdings (00700) repurchased 1.06 million shares for a total of 636 million, representing 0.961% of its total share capital [2] - Xiaomi Group-W (01810) repurchased 2.4 million shares for 101 million, accounting for 0.400% of its total share capital [2] - China Feihe (06186) repurchased 5.47 million shares for 22.94 million, which is 2.521% of its total share capital [2] Group 2: Other Notable Buybacks - Geely Automobile (00175) repurchased 1.54 million shares for 27.14 million, representing only 0.047% of its total share capital [2] - Kweichow Moutai (600519) repurchased 204,000 shares for 8.82 million, which is 0.180% of its total share capital [2] - Vitasoy International (00345) repurchased 404,000 shares for 2.67 million, accounting for 2.180% of its total share capital [2] Group 3: Companies with Lower Buyback Amounts - 康臣药业 (01681) repurchased 354,000 shares for 5.28 million, which is 15.048% of its total share capital [2] - 瑞声科技 (02018) repurchased 150,000 shares for 5.76 million, representing 0.492% of its total share capital [2] - 周黑鸭 (01458) repurchased 160,500 shares for 2.68 million, which is 1.407% of its total share capital [3]

备注：以上数据由格隆汇数据中心根据港交所数据加工计算所得，并不保证100%精确。 本文源自：格隆汇 股票名称 回购数 回购额 年累计回购数量(股) 年累计回购数量/总股本 腾讯控股(00700) 106.00万 6.36亿 8831.30万 0.961% 小米集团-W(01810) 240.00万 1.01亿 1.03亿 0.400% 中远海控(01919) 300.00万 4085.81 万 7854.30万 2.727% 纳芯微(02676) 20.15万 3067.05万 null null 顺丰控股(06936) 81.55万 3042.25万 null null 碧桂园服务(06098) 468.40万 2921.95万 3691.40万 1.105% 吉利汽车(00175) 153.70万 2713.61万 470.50万 0.047% 中国飞鹤(06186) 547.00万 2293.91万 2.29亿 2.521% 巨子生物(02367) 40.00万 1438.24万 80.00万 0.075% 金山软件(03888) 34.50万 999.72万 707.32万 0.510% 中国石油化工 ...

证券时报·数据宝统计，中国飞鹤在港交所公告显示，12月10日以每股4.120港元至4.200港元的价格回购 547.00万股，回购金额达2293.91万港元。该股当日收盘价4.160港元，上涨0.73%，全天成交额1.18亿港 元。 自10月24日以来公司已连续33日进行回购，合计回购2.27亿股，累计回购金额9.63亿港元。 其间该股累 计上涨3.48%。 今年以来该股累计进行35次回购，合计回购2.29亿股，累计回购金额9.73亿港元。（数据宝） 中国飞鹤回购明细 （文章来源：证券时报网） | 日期 | 回购股数（万股） | 回购最高价（港元） | 回购最低价（港元） | 回购金额（万港元） | | --- | --- | --- | --- | --- | | 2025.12.10 | 547.00 | 4.200 | 4.120 | 2293.91 | | 2025.12.09 | 800.70 | 4.120 | 4.070 | 3292.83 | | 2025.12.08 | 700.00 | 4.130 | 4.090 | 2874.82 | | 2025.12.05 | 300.00 | 4. ...

格隆汇12月10日丨中国飞鹤(06186.HK)发布公告，2025年12月10日耗资2293.91万港元回购547万股，回 购价格每股4.12-4.2港元。 中国飞鹤(06186.HK)12月10日耗资2293.91万港元回购547万股 中国飞鹤(06186.HK)12月9日耗资3292.8万 港元回购800.7万股 相关事件 ...